CML & PH+ All: There is so much more to know CML & PH+ All: There is so much more to know Explore
Think | Test | Treat

WHAT IS THINK
TEST TREAT?

The THINK TEST TREAT programme was initiated by Incyte to raise awareness of the importance of regular and sensitive BCR-ABL1 monitoring and guidance-compliant mutation testing in patients with Ph+ leukaemias

Read more

CML

Why is It important to think about sensitive BCR-ABL1 monitoring and mutation testing when treating patients with CML?

Read more

Ph+ ALL

Why is it important to monitor minimal residual disease and test for mutations when treating patients with Ph+ ALL?

Read more

For further information, please contact Incyte Medical Information: eumedinfo@incyte.com